trial · primary record
Qurse Revand
MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 128 |
| Primary completion | 2029-05-01 |
| Primary endpoint | Change in Fatty Liver Grading by USG |
| Registry ID | NCT07902219 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:41:26.766Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07902219
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.